Loading the section
Prices delayed by 15 minutes
Next earnings report: none scheduled in the next five weeks · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Genmab A/S trades on Nasdaq under the ticker GMAB. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks GMAB has traded between 23.62 $ and 40.17 $. As of 09 October 2026 the price stood 75.11 % of the way from the 52-week low to the high.
Over one year GMAB shares rose 10.45 %; over six months they rose 27.48 %. Volatility over 90 days is 35.30 %. Dividends are not included: this is price change only, as of 09 October 2026.
Genmab A/S reported revenue of 3.7B $ and net income of 963M $ for the latest fiscal year. Net margin is 25.89 %. Revenue changed by +19.19 % year over year. Earnings per share are 15.37 $.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 08 October 2026 | 36.18 | 36.29 | 35.09 | 36.05 | 4M |
| 07 October 2026 | 37.28 | 37.87 | 36.27 | 36.65 | 4M |
| 06 October 2026 | 39.11 | 39.15 | 37.07 | 37.80 | 7M |
| 05 October 2026 | 35.09 | 40.17 |
Based on the fiscal year ended 31 December 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
Genmab A/S (GMAB) is a public company in the healthcare sector. Its depositary receipts trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 3.7bn $, net income was 963.0m $.
This summary is compiled automatically from SEC filings and exchange data.
Address:TOLDBODGADE 33, 1253 COPENHAGEN K, 00000, DK
GMAB has a return on equity of 16.47 %, above the sector median of −41.68 %. Return on assets is 7.48 %, above the sector median of −32.11 %. Operating margin is 28.63 %, above the sector median of −26.84 %.
| GPCRStructure Therapeutics Inc. | 25.60 | −0.29 % | 49M |
| LEGNLegend Biotech Corporation | 18.62 | −0.48 % | 40M |
| BLTEBelite Bio, Inc | 154.06 | +1.01 % | 33M |
| ZLABZai Lab Limited | 24.99 | +0.73 % | 21M |
| 35.02 |
| 38.48 |
| 12M |
| 02 October 2026 | 34.39 | 35.02 | 33.73 | 34.75 | 5M |
| 01 October 2026 | 35.25 | 35.80 | 34.52 | 34.55 | 6M |
| 30 September 2026 | 35.72 | 35.91 | 35.37 | 35.68 | 5M |
| 29 September 2026 | 34.94 | 35.64 | 34.89 | 35.57 | 4M |
| 28 September 2026 | 34.76 | 35.70 | 34.63 | 35.36 | 3M |
| 25 September 2026 | 34.95 | 35.47 | 34.70 | 35.32 | 4M |
| 24 September 2026 | 34.69 | 35.03 | 34.36 | 34.83 | 3M |
| 23 September 2026 | 35.39 | 35.66 | 34.61 | 34.75 | 3M |
| 22 September 2026 | 34.46 | 35.30 | 34.37 | 35.22 | 2M |
| 21 September 2026 | 34.70 | 34.87 | 34.36 | 34.69 | 2M |
| 18 September 2026 | 34.92 | 35.15 | 34.72 | 34.74 | 3M |
| 17 September 2026 | 34.28 | 34.77 | 34.22 | 34.54 | 3M |
| 16 September 2026 | 34.36 | 34.63 | 34.05 | 34.40 | 3M |
| 15 September 2026 | 32.34 | 34.19 | 32.34 | 34.15 | 3M |
| 14 September 2026 | 32.79 | 32.96 | 32.52 | 32.65 | 1M |
| 11 September 2026 | 32.45 | 32.70 | 32.27 | 32.47 | 1M |